logo

Anthera Pharmaceuticals, Inc. (ANTH)



Trade ANTH now with
  Date
  Headline
6/27/2018 8:07:11 AM Anthera Announces Withdrawal Of Nasdaq Hearing Request And Suspension Of Trading Of Securities On NASDAQ
3/12/2018 8:07:39 AM Anthera Pharma Reports Top Line Data From RESULT Phase 3 Clinical Study Of Sollpura
3/5/2018 4:10:56 PM Anthera Pharma Q4 Loss/share $0.73 Vs. Loss $2.84 Year Ago
1/22/2018 8:35:00 AM Anthera Announces Positive Outcome Of Second Interim Futility Analysis In Phase 3 RESULT Clinical Study Of Sollpura
11/1/2011 12:39:05 PM Deutsche Bank Initiates Anthera Pharmaceuticals, Inc. (ANTH) At Buy With $14 Price Target
  
 
>